These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9865509)

  • 1. Tranilast, an anti-allergic drug, possesses antagonistic potency to angiotensin II.
    Jin D; Takai S; Shiota N; Miyazaki M
    Eur J Pharmacol; 1998 Nov; 361(2-3):199-205. PubMed ID: 9865509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranilast antagonizes angiotensin II and inhibits its biological effects in vascular smooth muscle cells.
    Miyazawa K; Fukuyama J; Misawa K; Hamano S; Ujiie A
    Atherosclerosis; 1996 Apr; 121(2):167-73. PubMed ID: 9125291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profiles of a novel non-peptide angiotensin II type I receptor antagonist HR720 in vitro and in vivo.
    Jin D; Song K; Oka Y; Takai S; Shiota N; Miyazaki M
    Jpn J Pharmacol; 1997 Nov; 75(3):259-66. PubMed ID: 9434257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
    Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
    Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranilast inhibits contraction and Ca2+ movement of porcine coronary arteries.
    Ishibashi S; Ikeda U; Ihara T; Shimada K
    Atherosclerosis; 1997 Apr; 130(1-2):113-9. PubMed ID: 9126655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranilast inhibits the proliferation of human coronary smooth muscle cell through the activation of p21waf1.
    Kusama H; Kikuchi S; Tazawa S; Katsuno K; Baba Y; Zhai YL; Nikaido T; Fujii S
    Atherosclerosis; 1999 Apr; 143(2):307-13. PubMed ID: 10217359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonist.
    Noda M; Shibouta Y; Inada Y; Ojima M; Wada T; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    Biochem Pharmacol; 1993 Jul; 46(2):311-8. PubMed ID: 8347154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II-induced responses in vascular smooth muscle cells: inhibition by non-peptide receptor antagonists.
    Catalioto RM; Porchia R; Renzetti AR; Criscuoli M; Subissi A; Giachetti A
    Eur J Pharmacol; 1995 Jul; 280(3):285-92. PubMed ID: 8566096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranilast suppresses vascular chymase expression and neointima formation in balloon-injured dog carotid artery.
    Shiota N; Okunishi H; Takai S; Mikoshiba I; Sakonjo H; Shibata N; Miyazaki M
    Circulation; 1999 Mar; 99(8):1084-90. PubMed ID: 10051304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of TCV-116 and CV-11974 on angiotensin II-induced responses in vascular smooth muscle cells.
    Flesch M; Ko Y; Seul C; Düsing R; Feltkamp H; Vetter H; Sachinidis A
    Eur J Pharmacol; 1995 Apr; 289(2):399-402. PubMed ID: 7621917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibitory effect of KT3-671, a nonpeptide angiotensin-receptor antagonist, on rabbit and rat isolate vascular smooth muscles: a possible involvement of K(ATP) channels.
    Satake N; Imanishi M; Keto Y; Ishikawa M; Yamada H; Shibata S; Tomiyama A
    J Cardiovasc Pharmacol; 2000 Mar; 35(3):457-67. PubMed ID: 10710133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277.
    Wienen W; Hauel N; Van Meel JC; Narr B; Ries U; Entzeroth M
    Br J Pharmacol; 1993 Sep; 110(1):245-52. PubMed ID: 8220885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pemirolast and tranilast on intimal thickening after arterial injury in the rat.
    Miyazawa N; Umemura K; Kondo K; Nakashima M
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):157-62. PubMed ID: 9269941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist.
    Shibasaki M; Fujimori A; Takanashi M; Kusayama T; Tokioka T; Satoh Y; Okazaki T; Uchida W; Inagaki O; Yanagisawa I
    Eur J Pharmacol; 1997 Sep; 335(2-3):167-73. PubMed ID: 9369370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranilast inhibits contraction of rat aortic smooth muscle.
    Ihara T; Ikeda U; Ishibashi S; Shimada K
    Eur J Pharmacol; 1997 Jun; 329(1):43-8. PubMed ID: 9218682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of a potent long-acting imidazole-5-acrylic acid angiotensin AT1 receptor antagonist.
    Aiyar N; Baker E; Vickery-Clark L; Ohlstein EH; Gellai M; Fredrickson TA; Brooks DP; Weinstock J; Weidley EF; Edwards RM
    Eur J Pharmacol; 1995 Sep; 283(1-3):63-72. PubMed ID: 7498322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro pharmacological characterization of a new selective angiotensin AT1 receptor antagonist, UR-7280.
    De Arriba AF; Gómez-Casajús LA; Cavalcanti F; Almansa C; García-Rafanell J; Forn J
    Eur J Pharmacol; 1996 Dec; 318(2-3):341-7. PubMed ID: 9016924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different prejunctional and postjunctional responses to angiotensin II and AT1-receptor inhibition: influence of maturation.
    Nap A; Mathy MJ; Pfaffendorf M; van Zwieten PA
    J Cardiovasc Pharmacol; 2004 Mar; 43(3):432-9. PubMed ID: 15076228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prominent inhibitory effects of tranilast on migration and proliferation of and collagen synthesis by vascular smooth muscle cells.
    Tanaka K; Honda M; Kuramochi T; Morioka S
    Atherosclerosis; 1994 Jun; 107(2):179-85. PubMed ID: 7526874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.